MECHANISMS OF RENAL ADAPTATION TO ANOXIA
肾脏适应缺氧的机制
基本信息
- 批准号:7479724
- 负责人:
- 金额:$ 25.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acute Kidney FailureAddressAffinityAnoxiaApoptoticBiologicalBiological PhenomenaBrainBrain Hypoxia-IschemiaCell Death InductionCellsCellular StructuresChronicClassConnexinsDepthDown-RegulationEnsureEpithelial CellsExperimental DesignsGene FamilyGene ProteinsGene SilencingGenesHeartHeat shock proteinsHeat-Shock ResponseHomeostasisHypoxiaHypoxia Inducible FactorHypoxia PathwayImaging TechniquesInfant CareInjuryIntercalated discIschemiaKidneyMetabolicMetabolismMicroarray AnalysisMolecularNatural regenerationNephronsNeurogliaNeuronsNumbersOligonucleotidesOutcome MeasureOxygenPathway interactionsPlayPreparationProcessProteinsProteomicsRNA InterferenceRattusResearchResearch DesignResistanceResistance developmentRoleStressSuspension CultureSystemTechniquesTestingTherapeutic Interventionbasecell injurydeprivationdesignheat shock transcription factorinjuredkidney cellprotective effectprotein expressionrenal epitheliumresponsetranscription factor
项目摘要
The broad objective of this project is an advanced understanding of molecular processes by which the immature nephron is protected from both oxygen deprivation and ischemic insults. Two classes of genes which are induced by ischemia or hypoxia have been shown to be over expressed constitutively in the immature kidney, the heat shock response (HSR) and the hypoxia responsive pathway (HRP). Each of these ubiquitous biological systems may play a fundamental role in the innate tolerance to injury manifested by the immature nephron. Specific Aim 1 will evaluate the HSR by determining if down-regulation of either constitutive activation of Heat Shock Transcription Factor (HSF) or diminution of HSP72 and/or HSP25 expression will impair tolerance to injury in immature nephrons. Specific Aim 2 will investigate HRP by delineating effects of inhibition of Hypoxia Inducible Factor (HIF-1) activity and synthesis of hemoxygenase and erythropoitin following hypoxic or ischemic insults in immature kidneys. Both specific aims will test a common hypothesis: if tolerance of the immature nephron is dependent on the activity of transcription factors and/or abundance of proteins which are constitutively over-expressed compared to the mature kidney, then dampening of transcription factor activity and/or inhibition of synthesis of specific proteins will increase the vulnerability of the immature nephron to a hypoxic or ischemic injury. The proposed studies utilize new techniques for gene silencing
which allow a) global dampening of families of genes controlled by a common transcription factor (oligonucleotide decoys) and b) specific inhibition of synthesis of selected proteins (short interference RNA, siRNA). To ensure the feasibility of the experimental design, transcription factor decoys for HSF and HIF-1 have been developed and validated in LLCPK cells, as well as suspensions and cultures of immature proximal tubules. In addition, two target sequences for HSP72 siRNA have been identified and shown to specifically inhibit synthesis of HSP72 but not HSP25 in LLCPK cells after ATP depletion. The developing kidney, in which cytoprotective proteins are up-regulated without prior stress, represents an ideal and somewhat unique circumstance in which to delineate molecular mechanisms and pathobiologic processes which are fundamental to cellular injury in the mature kidney. Moreover, an in-depth understanding in the immature kidney will be important so that therapeutic interventions which might offset the
protective effects can be avoided in care of infants with acute renal failure.
该项目的总体目标是深入了解保护未成熟肾单位免受缺氧和缺血性损伤的分子过程。两类由缺血或缺氧诱导的基因已被证明在未成熟的肾脏中组成型过度表达,即热休克反应(HSR)和缺氧反应途径(HRP)。这些普遍存在的生物系统中的每一个都可能在未成熟肾单位表现出的先天损伤耐受性中发挥重要作用。具体目标 1 将通过确定热休克转录因子 (HSF) 组成型激活的下调或 HSP72 和/或 HSP25 表达的减少是否会损害未成熟肾单位对损伤的耐受性来评估 HSR。具体目标 2 将通过描述未成熟肾脏缺氧或缺血损伤后抑制缺氧诱导因子 (HIF-1) 活性以及血氧合酶和红细胞生成素合成的影响来研究 HRP。这两个具体目标都将检验一个共同的假设:如果未成熟肾单位的耐受性取决于转录因子的活性和/或与成熟肾相比组成性过度表达的蛋白质的丰度,那么转录因子活性的抑制和/或抑制特定蛋白质的合成将增加未成熟肾单位对缺氧或缺血性损伤的脆弱性。拟议的研究利用基因沉默新技术
它允许 a) 对由共同转录因子(寡核苷酸诱饵)控制的基因家族进行全局抑制,以及 b) 对选定蛋白质的合成进行特异性抑制(短干扰 RNA,siRNA)。为了确保实验设计的可行性,HSF 和 HIF-1 的转录因子诱饵已在 LLCPK 细胞以及未成熟近端小管的悬浮液和培养物中进行了开发和验证。此外,HSP72 siRNA 的两个靶序列已被鉴定,并显示在 ATP 耗尽后特异性抑制 LLCPK 细胞中 HSP72 的合成,但不抑制 HSP25。发育中的肾脏,其中细胞保护蛋白在没有先前应激的情况下上调,代表了一种理想且有些独特的环境,在这种环境中描述了成熟肾脏中细胞损伤的基础分子机制和病理生物学过程。此外,对未成熟肾脏的深入了解也很重要,这样治疗干预措施可能会抵消
在护理患有急性肾功能衰竭的婴儿时可以避免保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Kashgarian其他文献
Michael Kashgarian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Kashgarian', 18)}}的其他基金
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The regulation of renal tubular transport by cannabinoid receptor type 1 (CB1R) and its endogenous lipid ligands
1型大麻素受体(CB1R)及其内源性脂质配体对肾小管转运的调节
- 批准号:
10588113 - 财政年份:2023
- 资助金额:
$ 25.58万 - 项目类别:
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease
红细胞 2,3 DPG 的动态变化是终末期肾病心脏功能障碍的驱动因素
- 批准号:
10254626 - 财政年份:2021
- 资助金额:
$ 25.58万 - 项目类别:
Dynamic Changes in Erythrocyte 2,3 DPG as a Driver of Cardiac Dysfunction in End Stage Kidney Disease
红细胞 2,3 DPG 的动态变化是终末期肾病心脏功能障碍的驱动因素
- 批准号:
10662216 - 财政年份:2021
- 资助金额:
$ 25.58万 - 项目类别:
Mechanisms of alloantibody production following renal transplantation
肾移植后同种抗体产生的机制
- 批准号:
10357956 - 财政年份:2021
- 资助金额:
$ 25.58万 - 项目类别:
Mechanisms of alloantibody production following renal transplantation
肾移植后同种抗体产生的机制
- 批准号:
10228265 - 财政年份:2021
- 资助金额:
$ 25.58万 - 项目类别: